> **来源：[研报客](https://pc.yanbaoke.cn)** ```markdown # Summary of Stax PE Investor Survey: Healthcare 2025 ## Core Content The **Stax PE Investor Survey: Healthcare 2025** provides an in-depth analysis of the current state and future outlook of healthcare private equity (PE) investments. The report highlights a mix of optimism and caution among investors, influenced by macroeconomic factors, tariff uncertainty, and evolving market dynamics. ## Main Views - **Investor Sentiment**: Despite tariff-related uncertainty, investor sentiment has strengthened in 2025. About **80%** of surveyed healthcare-focused PE investors remain optimistic about deal flow, with **52%** expressing **high optimism** for the remainder of the year. - **Drivers of Increased Deal Activity**: The primary factors driving increased deal activity in 2025 include: - Attractive assets coming to market (70% of respondents) - Declining interest rates (53%) - Pressure from LPs to return capital (27%) - Long hold periods for existing assets (40%) - **Capital Deployment Expectations**: On average, investors anticipate deploying **6% more healthcare capital in 2025** compared to 2024, with this expectation remaining consistent before and after tariff implementation. - **Tariff Impact**: Tariffs are expected to have a **moderate to minor impact** on deal flow, with **48%** of investors anticipating only a minor effect and **38%** expecting a moderate impact. Asset valuations are expected to rise by about **2%** on average, though **70%** of investors still anticipate a **single-digit valuation increase**. - **Thematic Investment Areas**: The top three thematic areas of focus for healthcare PE investors in 2025 are: 1. **Healthcare Facilities** (e.g., SNFs, ASCs, dialysis centers) 2. **Hospital Operations Technology** (e.g., scheduling optimization, compliance software) 3. **Retail Health** (e.g., urgent care centers) Other notable areas include **non-physician services** (e.g., dental, physical therapy) and **pharma tech and outsourced services**. - **Due Diligence Considerations**: Due to tariff uncertainty, investors are increasingly focusing on: - **Customer pricing sensitivity** (86% of respondents) - **Country of origin tracing** (72%) - **Supply chain analysis** (56%) - **Supplier relationship strength** (40%) - **Inventory contingency planning** (30%) - **CapEx impact from sourcing relocation** (28%) - **AI in Healthcare Investment**: AI is expected to play a **significant role** in 2025 healthcare deal activity, particularly in: - **Hospital operations technology** - **Facility optimization** - **Consumer-driven health** AI is seen as a **complementary tool** to enhance workflows and improve outcomes, rather than a substitute for human expertise. - **Investor Focus in Specific Areas**: - **Healthcare Facilities**: Hospitals and urgent care centers remain a key focus, with technology-driven solutions for compliance, cybersecurity, and capacity management in high demand. - **Healthcare Services**: Retail health and consumer-driven services like medspas are of interest, though reimbursement risk remains a concern. - **Dental Services**: High fragmentation continues to make DSO consolidation an attractive exit strategy. - **Pharma Tech and Outsourced Services**: Clinical trial technology and pharma marketing tech are in focus, especially in oncology, rare disease, and neurology. - **Physician Practice Management (PPM)**: Primary care remains the most in-demand area, with a focus on value-based care models. ## Key Information - **Survey Sample**: The survey included **200 respondents**, comprising healthcare PE investors with varying fund sizes and titles (e.g., Managing Director, Director, Partner). - **Tariff Impact on Asset Valuations**: While tariffs have increased sourcing costs, they are not expected to drastically reduce deal activity. Investors are more focused on **customer pricing sensitivity** than on supply chain or country of origin analysis. - **Stax Healthcare Team**: Stax has a highly specialized healthcare team with **30+ years of experience**, offering strategic and operational expertise to support PE firms throughout the investment lifecycle. - **POTLOC**: POTLOC is a leading survey platform that provides high-quality data and AI-powered analysis to help firms make informed investment decisions. It has supported over **500 global firms** in collecting insights across industries and geographies. ## Conclusion The 2025 healthcare PE investment landscape is characterized by **increased deal activity**, **AI integration**, and **strategic focus on facilities and technology**. While tariffs introduce uncertainty, they are not expected to derail investment momentum. Investors are adopting more rigorous due diligence practices and prioritizing areas with strong growth potential and operational efficiency. ```